These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 24945990)
1. Survivin delta Ex3 overexpression in thyroid malignancies. Waligórska-Stachura J; Andrusiewicz M; Sawicka-Gutaj N; Biczysko M; Jankowska A; Kubiczak M; Czarnywojtek A; Wrotkowska E; Ruchała M PLoS One; 2014; 9(6):e100534. PubMed ID: 24945990 [TBL] [Abstract][Full Text] [Related]
2. Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression. Sawicka-Gutaj N; Waligórska-Stachura J; Andrusiewicz M; Biczysko M; Sowiński J; Skrobisz J; Ruchała M Tumour Biol; 2015 Sep; 36(10):7859-63. PubMed ID: 25946974 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of survivin splice variants in pituitary tumors. Waligórska-Stachura J; Andrusiewicz M; Sawicka-Gutaj N; Kubiczak M; Jankowska A; Liebert W; Czarnywojtek A; Waśko R; Blanco-Gangoo AR; Ruchała M Pituitary; 2015 Jun; 18(3):410-6. PubMed ID: 25107550 [TBL] [Abstract][Full Text] [Related]
4. Targeting of the anti-apoptotic gene survivin in human thyroid carcinoma. Chen Z; Liu N; Zhu G; Dralle H; Hoang-Vu C Int J Mol Med; 2012 Sep; 30(3):465-72. PubMed ID: 22751750 [TBL] [Abstract][Full Text] [Related]
5. Detection of survivin 2α gene expression in thyroid nodules. Kyani K; Babaei E; Feizi MA; Vandghanooni S; Montazeri V; Halimi M J Cancer Res Ther; 2014; 10(2):312-6. PubMed ID: 25022384 [TBL] [Abstract][Full Text] [Related]
6. Survivin-deltaEx3: a novel biomarker for diagnosis of papillary thyroid carcinoma. Vandghanooni S; Eskandani M; Montazeri V; Halimi M; Babaei E; Feizi MA J Cancer Res Ther; 2011; 7(3):325-30. PubMed ID: 22044815 [TBL] [Abstract][Full Text] [Related]
7. BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Moore AS; Alonzo TA; Gerbing RB; Lange BJ; Heerema NA; Franklin J; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S Pediatr Blood Cancer; 2014 Apr; 61(4):647-52. PubMed ID: 24127439 [TBL] [Abstract][Full Text] [Related]
8. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Mahotka C; Krieg T; Krieg A; Wenzel M; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD Int J Cancer; 2002 Jul; 100(1):30-6. PubMed ID: 12115583 [TBL] [Abstract][Full Text] [Related]
9. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance]. He XF; Wen DG; Hou JQ; He J; Cen JN Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744 [TBL] [Abstract][Full Text] [Related]
10. Early diagnostic value of survivin and its alternative splice variants in breast cancer. Khan S; Bennit HF; Turay D; Perez M; Mirshahidi S; Yuan Y; Wall NR BMC Cancer; 2014 Mar; 14():176. PubMed ID: 24620748 [TBL] [Abstract][Full Text] [Related]
11. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers. Pannone G; Santoro A; Pasquali D; Zamparese R; Mattoni M; Russo G; Landriscina M; Piscazzi A; Toti P; Cignarelli M; Lo Muzio L; Bufo P Thyroid; 2014 Mar; 24(3):511-9. PubMed ID: 24117205 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer. Moniri Javadhesari S; Gharechahi J; Hosseinpour Feizi MA; Montazeri V; Halimi M Genet Test Mol Biomarkers; 2013 Apr; 17(4):314-20. PubMed ID: 23368531 [TBL] [Abstract][Full Text] [Related]
13. Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance. Selemetjev SA; Savin SB; Paunovic IR; Tatic SB; Cvejic D Wien Klin Wochenschr; 2015 May; 127(9-10):337-44. PubMed ID: 25471003 [TBL] [Abstract][Full Text] [Related]
14. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas. Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional expression of survivin and its splice variants in endometriosis. Fujino K; Ueda M; Takehara M; Futakuchi H; Kanda K; Yamashita Y; Terai Y; Ueki M Mol Hum Reprod; 2006 Jun; 12(6):383-8. PubMed ID: 16644787 [TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma. Huang Y; Chen X; Chen N; Nie L; Xu M; Zhou Q J Clin Pathol; 2011 Nov; 64(11):953-9. PubMed ID: 21730264 [TBL] [Abstract][Full Text] [Related]
17. High expression of survivin and its splice variants survivin ΔEx3 and survivin 2 B in oral cancers. Mishra R; Palve V; Kannan S; Pawar S; Teni T Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Oct; 120(4):497-507. PubMed ID: 26346910 [TBL] [Abstract][Full Text] [Related]